These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Mesenchymal stem cell therapy for heart disease. Gnecchi M; Danieli P; Cervio E Vascul Pharmacol; 2012 Aug; 57(1):48-55. PubMed ID: 22521741 [TBL] [Abstract][Full Text] [Related]
4. Paracrine effects and heterogeneity of marrow-derived stem/progenitor cells: relevance for the treatment of respiratory diseases. Conese M; Carbone A; Castellani S; Di Gioia S Cells Tissues Organs; 2013; 197(6):445-73. PubMed ID: 23652321 [TBL] [Abstract][Full Text] [Related]
5. The burden of lung disease: the need for stem cell therapy--a review series prologue. Moodley Y; Thompson PJ Respirology; 2013 Apr; 18(3):393-6. PubMed ID: 23347133 [No Abstract] [Full Text] [Related]
6. The potential of cell-based therapy in lung diseases. Huleihel L; Levine M; Rojas M Expert Opin Biol Ther; 2013 Oct; 13(10):1429-40. PubMed ID: 23984902 [TBL] [Abstract][Full Text] [Related]
7. Specific subsets of mesenchymal stroma cells to treat lung disorders--finding the Holy Grail. Rolandsson S; Karlsson JC; Scheding S; Westergren-Thorsson G Pulm Pharmacol Ther; 2014 Dec; 29(2):93-5. PubMed ID: 25239767 [TBL] [Abstract][Full Text] [Related]
8. Cell surface structures influence lung clearance rate of systemically infused mesenchymal stromal cells. Nystedt J; Anderson H; Tikkanen J; Pietilä M; Hirvonen T; Takalo R; Heiskanen A; Satomaa T; Natunen S; Lehtonen S; Hakkarainen T; Korhonen M; Laitinen S; Valmu L; Lehenkari P Stem Cells; 2013 Feb; 31(2):317-26. PubMed ID: 23132820 [TBL] [Abstract][Full Text] [Related]
9. Role of bone marrow and mesenchymal stem cells in healing after traumatic injury. Hannoush EJ; Elhassan I; Sifri ZC; Mohr AA; Alzate WD; Livingston DH Surgery; 2013 Jan; 153(1):44-51. PubMed ID: 22862904 [TBL] [Abstract][Full Text] [Related]
10. Improved cell survival and paracrine capacity of human embryonic stem cell-derived mesenchymal stem cells promote therapeutic potential for pulmonary arterial hypertension. Zhang Y; Liao S; Yang M; Liang X; Poon MW; Wong CY; Wang J; Zhou Z; Cheong SK; Lee CN; Tse HF; Lian Q Cell Transplant; 2012; 21(10):2225-39. PubMed ID: 22776744 [TBL] [Abstract][Full Text] [Related]
11. The effects of microenvironment in mesenchymal stem cell-based regeneration of intervertebral disc. Huang YC; Leung VY; Lu WW; Luk KD Spine J; 2013 Mar; 13(3):352-62. PubMed ID: 23340343 [TBL] [Abstract][Full Text] [Related]
12. Lessons from genetically altered mesenchymal stem cells (MSCs): candidates for improved MSC-directed myocardial repair. Alfaro MP; Young PP Cell Transplant; 2012; 21(6):1065-74. PubMed ID: 22080676 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic potential of intravenously administered human mesenchymal stromal cells. Kollar K; Seifried E; Henschler R Hamostaseologie; 2011 Nov; 31(4):269-74. PubMed ID: 22064918 [TBL] [Abstract][Full Text] [Related]
14. Nestin-positive mesenchymal stem cells favour the astroglial lineage in neural progenitors and stem cells by releasing active BMP4. Wislet-Gendebien S; Bruyère F; Hans G; Leprince P; Moonen G; Rogister B BMC Neurosci; 2004 Sep; 5():33. PubMed ID: 15369599 [TBL] [Abstract][Full Text] [Related]
20. Regeneration of cartilage and bone by defined subsets of mesenchymal stromal cells--potential and pitfalls. Aicher WK; Bühring HJ; Hart M; Rolauffs B; Badke A; Klein G Adv Drug Deliv Rev; 2011 Apr; 63(4-5):342-51. PubMed ID: 21184789 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]